[Periodontal tissue engineering by FGF-2:Its present status and future outlook].
Periodontitis remains highly prevalent all over the world and can lead to loss of the affected teeth. Thus, establishing a brand-new treatment that enables the regeneration and rebuilding of periodontal tissue destroyed by periodontitis represents a task of tremendous importance. Our pre-clinical studies and clinical trials suggested that efficacy is expected from basic fibroblast growth factor(FGF-2)in stimulating regeneration of periodontal tissue. Development of the osteoconductive carrier for FGF-2 drug will further extend the indications in the field of dental medicine.